Patents: Eastern Virginia Medical School

Patents and Patent Applications from Eastern Virginia Medical School

Matches 1 - 50 out of 69

1 2 >

Match	Document	Document Title
1	US20120016030	METHOXYPOLYETHYLENE GLYCOL THIOESTER CHELATE AND USES THEREOF The present invention is directed generally to protecting cells, tissues and organs against the damaging effects of ionizing or other damaging agents associated with radiation or chemotherapy, or...
2	8083678	System, method and medium for acquiring and generating standardized operator independent ultrasound images of fetal, neonatal and adult organs A system, method and medium for standardizing a manner of acquisition and display of ultrasound images. In one embodiment of the invention, a volumetric image of an organ is acquired in a...
3	US20110236979	Apparatus for Generating Electrical Pulses and Methods of Using Same A method and apparatus are provided for delivering an agent into a cell through the application of nanosecond pulse electric fields (“nsPEF's”). The method includes circuitry for delivery of an age...
4	8008347	Methoxypolyethylene glycol thioester chelate and uses thereof The present invention is directed generally to protecting cells, tissues and organs against the damaging effects of ionizing or other damaging agents associated with radiation or chemotherapy, or...
5	US20110136166	Imaging Mass Spectrometry for Improved Prostrate Cancer Diagnostics The invention provides biomarkers that can discriminate between prostate cancer and normal tissue as well as identification of associated metastatic disease. One biomarker was identified as a...
6	US20110092973	NANOSECOND PULSED ELECTRIC FIELDS CAUSE MELANOMAS TO SELF-DESTRUCT Methods for a new, drug-free therapy for treating solid skin tumors through the application of nanosecond pulsed electric fields (“nsPEFs”) are provided. In one embodiment of the invention, the cel...
7	US20110082375	TRANSVAGINAL ULTRASOUND PROBE SPECULUM A transvaginal ultrasound probe speculum is designed for use with a generally cylindrical elongated ultrasound probe. The speculum has an elongated blade having a proximal end and a distal end, and...
8	US20110079226	CERVICAL OCCLUDER A device for occluding a cervix has an elongated conduit sized and shaped to extend from a proximal end outside the vagina to a distal end near the cervix. A loop sized to fit around an exocervix...
9	US20110045590	CALCIUM-INFLUX INHIBITORY FACTOR AND METHOD OF ISOLATION THEREOF A purified factor isolated from human milk is provided. The factor is capable of inhibiting calcium-influx activity in polymorphonuclear leukocytes. A method for purification of the factor is also...
10	US20110039798	SUBSTITUTED NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL AND ANTIMICROBIAL PROPERTIES The present invention relates to fatty acid and fatty alcohol substituted nucleoside derivatives and nucleoside and nucleoside derivatives substituted on multivalent scaffolds (e.g., polymers,...
11	US20100298645	MAGNARETRACTOR SYSTEM AND METHOD A system and method for performing surgical procedures within a body cavity, e.g. abdomen, uses a magnetized device is utilized to allow a surgeon to control intra-abdominal organs and objects. The...
12	7811772	Apolipoprotein A-II isoform as a biomarker for prostate cancer The present invention provides a protein-based biomarker, ApoA-II isoform, that is useful in determining prostate cancer status in a patient. In particular, the biomarker of this invention is...
13	7704983	Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception Menses regulation and, when desired, contraception is achieved at low doses of estrogen and progestin, which otherwise would create episodes of breakthrough bleeding and/or withdrawal amenorrhea,...
14	US20100055106	METHODS FOR REGULATING COMPLEMENT CASCADE PROTEINS USING ASTROVIRUS COAT PROTEIN AND DERIVATIVES THEREOF The present invention provides a method for modulating the complement cascade by depleting the plasma of the functional activity of complement proteins and thereby reducing or eliminating...
15	US20090306205	METHOXYPOLYETHYLENE GLYCOL THIOESTER CHELATE AND USES THEREOF The present invention is directed generally to protecting cells, tissues and organs against the damaging effects of ionizing or other damaging agents associated with radiation or chemotherapy, or...
16	US20090305212	System, method and medium for simulating normal and abnormal medical conditions The present invention provides a system, method and medium for simulating medical conditions to facilitate medical training, that utilizes a roaming device configured to be mobile; a positioning...
17	US20090275924	Systems and Methods for Monitoring and Controlling Internal Pressure of an Eye or Body Part Systems and methods for automatically monitoring and controlling pressure in a body part are disclosed. The systems include an implantable tube with one open end of the tube implanted in the body...
18	US20090220574	SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE The present invention is directed to methods of inhibiting STDs by topically administering suramin or a derivative thereof to actual or potential sites of infection, and methods of preventing...
19	US20090215085	Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential The present invention discloses biomarkers and biomarker combinations that have prognostic value as predictors of the developmental potential of individual IVF-derived human embryos. In particular,...
20	US20090204334	LUNG CANCER BIOMARKERS Disclosed are protein biomarkers and their use in diagnosing lung cancer or to make a negative diagnosis in patients. Also disclosed are kits for the diagnosis of lung cancer that detect the...
21	7565201	Activation of calcium-mediated cell functions in cells and tissues, including aggregation of human platelets. by nanosecond pulsed electric fields Methods for inducing calcium mobilization in cells through the application of nanosecond pulsed electric fields (“nsPEFs”) are provided. The invention also provides a method of increasing int...
22	7538099	Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses Menses regulation and, when desired, contraception is achieved at low doses of estrogen and progestin, which otherwise would create episodes of breakthrough bleeding and/or withdrawal amenorrhea,...
23	7476693	Suramin and derivatives thereof as topical microbicide and contraceptive The present invention is directed to methods of inhibiting STDs by topically administering suramin or a derivative thereof to actual or potential sites of infection, and methods of preventing...
24	US20090011998	CALCIUM-INFLUX INHIBITORY FACTOR AND METHOD OF ISOLATION THEREOF A purified factor isolated from human milk is provided. The factor is capable of inhibiting calcium-influx activity in polymorphonuclear leukocytes. A method for purification of the factor is also...
25	US20080248500	Apolipoprotein A-II Isoform As A Biomarker For Prostate Cancer The present invention provides a protein-based biomarker, ApoA-II isoform, that is useful in determining prostate cancer status in a patient. In particular, the biomarker of this invention is...
26	7388028	Methoxypolyethylene glycol thioester chelate and uses thereof The present invention is directed generally to protecting cells, tissues and organs against the damaging effects of ionizing or other damaging agents associated with radiation or chemotherapy, or...
27	US20080137877	Subject actuated system and method for simulating normal and abnormal medical conditions The present invention provides a system and method for simulating medical conditions to facilitate medical training, that utilizes a stethoscope comprising an earpiece and a headpiece and...
28	US20080051393	Novel cannabinoids and methods of use Water- and lipid-soluble cannabinoid compounds that are agonists for CB1 and CB2 receptors are provided. The cannabinoid compounds are useful for the treatment of retinal neurodegenerative...
29	RE40119	Adjunctive therapy A growth such as a tumor, hypertrophied tissue or cyst is biopsied or more completely excised subsequent to the administration of an effective amount of a gonadotropin releasing hormone analog or...
30	US20080039524	Methoxypolyethylene glycol thioester chelate and uses thereof The present invention is directed generally to protecting cells, tissues and organs against the damaging effects of ionizing or other damaging agents associated with radiation or chemotherapy, or...
31	7256185	Control of selective estrogen receptor modulators The treatment of an estrogen sensitive condition by the administration of a selective estrogen receptor modulator is improved by additionally administering a progestationally active compound to the...
32	US20070087392	Method for diagnosing head and neck squamous cell carcinoma Disclosed are protein biomarkers and their use in diagnosing head and neck squamous cell carcinoma (HNSCC) or to make a negative diagnosis in patients. Also disclosed are kits for the diagnosis of...
33	US20070015117	System and method for automatic driver evaluation Embodiments of the present invention provide a system and method for automatic driver evaluation of a person's driving capabilities and render an outcome of pass or fail without the need for a...
34	US20060270625	Nutraceuticals for the treatment of neuropathy The invention describes a novel combination of neutraceuticals. The invention also provides novel kits comprising a novel combination of neutraceuticals. The invention also provides methods for...
35	US20060269531	Apparatus for generating electrical pulses and methods of using the same A method and apparatus are provided for delivering an agent into a cell through the application of nanosecond pulse electric fields (“nsPEF's”). The method includes circuitry for delivery of an age...
36	RE39351	High level of expression of INGAP in bacterial and eukaryotic cells Removal of the nucleotide sequence encoding the signal peptide from the INGAP coding sequence allows cultured cells to express substantial amounts of INGAP activity. Previous attempts have provided...
37	RE39299	INGAP protein involved in pancreatic islet neogenesis Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display...
38	US20060204958	Methods for diagnosing htlv-i-mediated diseases Protein biomarkers that may advantageously be utilized in aiding in, or making, a diagnosis of HTLV-I-associated myelopathy (HAM), adult T-cell leukemia (ATL) or a negative diagnosis are described....
39	7037663	Human zona pellucida protein 3 and uses thereof The present invention provides a method to determine sperm activity comprising the steps of: (a) contacting an appropriate concentration of human zona pellucida protein 3 with an appropriate amount...
40	US20060088894	Prostate cancer biomarkers Protein biomarkers that may advantageously be utilized in diagnosing prostate cancer, benign prostate hyperplasia or to make a negative diagnosis are described. Accordingly, in one aspect of the...
41	US20060088830	Protein biomarkers that distinguish prostate cancer from non-malignant cells This invention provides organic biomolecule markers (e.g., proteins) useful for differentiating prostate cancer, prostate intraepithelial neoplasia or benign prostate hyperplasia, from a negative...
42	RE39062	INGAP protein involved in pancreatic islet neogenesis Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display...
43	7019114	Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility The invention relates to methods for producing recombinant human zona pellucida protein (“rhZP3”) and glycosylated peptide having biological activity of binding to human spermatozoa. A human ova...
44	US20050251036	System, method and medium for acquiring and generating standardized operator independent ultrasound images of fetal, neonatal and adult organs A system, method and medium for standardizing a manner of acquisition and display of ultrasound images. In one embodiment of the invention, a volumetric image of an organ is acquired in a...
45	US20050214945	Htlv-I tax induced killing of p53 null cancer cells This invention is based on the finding that expression of an exogenous nucleic acid encoding a polypeptide having human T-cell leukemia virus type I (HTLV-1) Tax activity in p53 null cells results...
46	US20050004465	System, method and medium for generating operator independent ultrasound images of fetal, neonatal and adult organs A system, method and medium, for use in a medical-imaging environment, that acquires ultrasound image data for at least a portion of a body organ, utilizes data defining a reference plane for the...
47	US20030148362	Diagnostic microarray and method of use thereof A microarray device for the analysis of biological samples is provided. The device includes a liquid permeable layer having a plurality of microregions, each including a plurality of probe-labeled...
48	6326177	Method and apparatus for intracellular electro-manipulation A method for intracellular electro-manipulation is provided. The method includes applying at least one ultrashort electric field pulse to target cells. The ultrashort electric field pulse has...
49	US20010036965	Iodo-nonoxynol-9-derivatives and methods for their use Mono- and di-iodinated nonoxynol-9-derivatives and methods for their use are disclosed.
50	6281251	Iodo-nonoxynol-9-derivatives and methods for their use Mono- and di-iodinated nonoxynol-9-derivatives and methods for their use are disclosed.

Matches 1 - 50 out of 69

1 2 >